Glucose levels in the normal range predict incident diabetes in families with premature coronary heart disease

Diabetes Research and Clinical Practice

Volumn 74, Issue 3, 2006, Pages 267-273

  Reynolds, Stasia S ^a   Yanek, Lisa R ^a   Vaidya, Dhananjay ^a   Mora, Samia ^a   Moy, Taryn F ^a   Saudek, Christopher D ^a   Becker, Lewis C ^a   Becker, Diane M ^a  

^a Division of General Internal Medicine   (United States)

Author keywords

Coronary heart disease; Families; Incident diabetes; Prevention

Indexed keywords

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; AGING; BLOOD GLUCOSE; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 33749992927     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.03.021     Document Type: Article

References (22)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 28 (2005) S37-S42
2. Levitan E.B., Song Y., Ford E.S., and Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?. Arch. Intern. Med. 164 (2004) 2147-2155
3. Deedwania P.C., and Fonseca V.A. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am. J. Med. 118 (2005) 939-947
4. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., and Day N. Association of haemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann. Intern. Med. 141 (2004) 413-420
5. Geiss L., Engelgau M., Pogach L., Acton K., Fleming B., Roman S., et al. A national progress report on diabetes: successes and challenges. Diabetes Technol. Ther. 7 (2005) 198-203
6. Rissanen A.M. Familial occurrence of coronary heart disease: effect of age at diagnosis. Am. J. Cardiol. 44 (1979) 60-66
7. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
8. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Finnish Diabetes Prevention Study Group: prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001) 1343-1350
9. Blumenthal R.S., Becker D.M., Yanek L.R., Aversano T.R., Moy T.F., Kral B.G., et al. Detecting occult coronary disease in a high-risk asymptomatic population. Circulation 107 (2003) 702-707
10. Expert panel on the identification, evaluation, and treatment of overweight in adults, clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary, Am. J. Clin. Nutr. 68 (1998) 899-917.
11. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentrations of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
12. Zeger S.L., Liang K.Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988) 1049-1060
13. Tirosh A., Shai I., Tekes-Manova D., Israeli E., Pereg D., Shochat T., et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N. Engl. J. Med. 353 (2005) 1454-1462
14. Edelstein S.L., Knowler W.C., Bain R.P., Andres R., Barrett-Connor E.L., Dowse G.K., et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46 (1997) 701-710
15. Brancati F.L., Kao W.H., Folsom A.R., Watson R.L., and Szklo M. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283 (2000) 2253-2259
16. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., and Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA 263 (1990) 2893-2898
17. Harris M.I., Klein R., Welborn T.A., and Knuiman M.W. Onset of NIDDM occurs atleast 4-7 years before clinical diagnosis. Diabetes Care 15 (1992) 815-819
18. Eddy D.M., Schlessinger L., and Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann. Intern. Med. 143 (2005) 251-264
19. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
20. Scuteri A., Najjar S.S., Morrell C.H., and Lakatta E.G. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events. Diabetes Care 28 (2005) 882-887
21. Shaw J.E., Zimmet P.Z., Hodge A.M., de Courten M., Dowse G.K., Chitson P., Tuomilehto J., and Alberti K.G. Impaired fasting glucose: how low should it go?. Diabetes Care 23 (2000) 34-39
22. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42 (2003) 1206-1252